Bank of Montreal’s BioNTech BNTX Stock Holding History

Bank of Montreal’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,200	Closed	-$1.22M	–	5077
2020 Q4	$1.22M	Buy	+11,200	New	+$1.1M	﹤0.01%	2104

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's BNTX Position: Q3 2024 in Review

Bank of Montreal sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 13,226 shares — an estimated $1.13M sold.

Bank of Montreal first reported a position in BNTX in Q2 2020 and held it in 15 quarters. The position peaked at $23.3M in Q1 2022. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

Bank of Montreal reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
Bank of Montreal sold 13,226 BioNTech shares in Q3 2024, an estimated $1.13M.
Bank of Montreal first reported a position in BioNTech in Q2 2020 and held it in 15 quarters.
Bank of Montreal's BioNTech position peaked at $23.3M in Q1 2022.
296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.